World Market Intelligence's 'Abbott India Limited (500488) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services.
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
WMI's 'Abbott India Limited (500488) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Examines and identifies key information and issues about 'Abbott India Limited' for business intelligence requirements
Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
Provides analysis on financial ratios along with a competitor benchmarking section
The profile also contains information on business operations, company history, major products and services, key employees
Reasons To Buy
Quickly enhance your understanding of the company
Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
Recognize potential partnerships and suppliers
Obtain yearly profitability figures
Abbott India Limited (Abbott) is a pharmaceutical company, which discovers, develops, manufactures and sells pharmaceutical, diagnostic, nutritional and hospital products in India and abroad. The company's products are used in a wide range of therapeutic areas, including: thyroid, obesity, diabetes, pain management, gastroenterology, prostate health, depression, epilepsy, sleep disorders, benign prostratic hyperplasia, and neurology and psychiatric segments, as well as in the fields of neonatology and anesthesiology. Some of the company's locally developed brands include Digene, Cremaffin, Epilex, Zolfresh and Obimet. The company's most significant global products include Brufen, Prothiaden, Ganaton, Sevorane, Thyronorm and Leptos. Abbott is headquartered at Mumbai, India.